Truist Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03M | Buy |
|
|||||
|
2025
Q1 | $3.9M | Sell |
|
|||||
|
2024
Q4 | $6.34M | Sell |
|
|||||
|
2024
Q3 | $24.7M | Buy |
|
|||||
|
2024
Q2 | $4.34M | Sell |
|
|||||
|
2024
Q1 | $5.15M | Buy |
|
|||||
|
2023
Q4 | $4.9M | Buy |
|
|||||
|
2023
Q3 | $4.02M | Buy |
|
|||||
|
2023
Q2 | $3.33M | Sell |
|
|||||
|
2023
Q1 | $4.21M | Sell |
|
|||||
|
2022
Q4 | $5.06M | Sell |
|
|||||
|
2022
Q3 | $4.68M | Sell |
|
|||||
|
2022
Q2 | $4.9M | Sell |
|
|||||
|
2022
Q1 | $5.74M | Buy |
|
|||||
|
2021
Q4 | $3.66M | Sell |
|
|||||
|
2021
Q3 | $4.34M | Buy |
|
|||||
|
2021
Q2 | $4.23M | Sell |
|
|||||
|
2021
Q1 | $4.46M | Buy |
|
|||||
|
2020
Q4 | $4.21M | Sell |
|
|||||
|
2020
Q3 | $4.28M | Buy |
|
|||||
|
2020
Q2 | $5.05M | Buy |
|
|||||
|
2020
Q1 | $3.53M | Buy |
|
|||||
|
2019
Q4 | $3.74M | Buy |
|